Showing results (11-20 of 435) with videos related to
Sort By:
Pageof 44
International Journal of Hematology|October 18, 2011
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myelomaSarah K Johnson, Christoph J Heuck, Anthony P Albino, et al.Seminars in Hematology|March 16, 2004
Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experienceBart BarlogieBlood|October 22, 2008
Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003Madhav V Dhodapkar, Antje Hoering, Morie A Gertz, et al.British Journal of Haematology|March 29, 2008
Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1Maurizio Zangari, Frits van Rhee, Elias Anaissie, et al.Blood|September 13, 2003
Treatment of multiple myelomaBart Barlogie, John Shaughnessy, Guido Tricot, et al.Biometrics|May 13, 2017
Multi-subgroup gene screening using semi-parametric hierarchical mixture models and the optimal discovery procedure: Application to a randomized clinical trial in multiple myelomaShigeyuki Matsui, Hisashi Noma, Pingping Qu, et al.Best Practice & Research. Clinical Haematology|December 12, 2007
The Arkansas approach to therapy of patients with multiple myelomaBart Barlogie, Elias Anaissie, Frits van Rhee, et al.Cancer|February 27, 2008
High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patientsMauricio Pineda-Roman, Bart Barlogie, Elias Anaissie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment armsBart Barlogie, Elias Anaissie, Frits van Rhee, et al.Haematologica|May 30, 2015
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)Rashid Khan, Madhav Dhodapkar, Adam Rosenthal, et al.Pageof 44